Clinical Report: Screening for Breast and Cervical Cancers in Gabon (2015–2021)
Overview
This study evaluates breast and cervical cancer screening outcomes in Franceville, Gabon, highlighting the effectiveness of clinical breast examination (CBE) and visual inspection with acetic acid (VIA). It identifies key sociodemographic factors influencing screening positivity and underscores the need for improved follow-up and data management.
Background
Breast and cervical cancers are significant public health concerns, particularly in sub-Saharan Africa, where screening programs are often underutilized. Gabon has established national screening initiatives, yet their effectiveness outside major urban centers like Libreville remains inadequately documented. Understanding screening outcomes in semi-urban areas is crucial for enhancing cancer control efforts.
Data Highlights
Variable
Odds Ratio (OR)
Confidence Interval (CI)
p-value
Cervical screening positivity (age 45-73 vs. 14-25)
0.52
0.29–0.90
0.021
Breast screening positivity (age at first pregnancy 30-39)
3.90
1.07–11.4
0.021
Key Findings
A total of 1,328 women participated in the screening study.
The mean age of participants was 35.4 years.
Women aged 45-73 had lower odds of cervical screening positivity compared to younger women.
Non-Gabonese nationality and public sector employment were associated with higher cervical screening positivity.
Age at first pregnancy between 30-39 years was linked to increased odds of breast screening positivity.
Follow-up systems and data management improvements are essential for enhancing screening effectiveness.
Clinical Implications
Healthcare providers should prioritize the implementation of accessible screening methods such as CBE and VIA in semi-urban settings. Additionally, addressing sociodemographic barriers and enhancing follow-up care can improve screening outcomes and cancer control in Gabon.
Conclusion
This study highlights the importance of routine breast and cervical cancer screening in semi-urban Gabon and the need for ongoing improvements in screening practices and follow-up systems to enhance cancer detection and management.
